Figure 5 | Hypertension Research

Figure 5

From: Impact of combined losartan/hydrochlorothiazide on proteinuria in patients with chronic kidney disease and hypertension

Figure 5

Changes in estimated glomerular filtration rate (eGFR) during the study period. The estimated GFR (mean±s.d.) values at 0, 6 and 12 months after the start of treatment are shown. There were no differences in eGFR between the losartan (LS) group (open circle and dash line) and the LS/hydrochlorothiazide (HCTZ) group (closed circle and solid line).

Back to article page